Eterna Therapeutics Inc. announced the appointment of Mahendra Rao, PhD, to its scientific advisory board. Dr. Mahendra Rao joins the Eterna Therapeutics Scientific Advisory Board with a wealth of experience in bringing novel treatments to and through clinical trials. Mahendra Rao is the Chief Scientific Officer of Vita Therapeutics Inc., a cell engineering company that uses induced pluripotent stem cell technology to engineer specific cell types designed to replace those that are defective in patients.

Dr. Mahendra Rao is internationally recognized for his research involving pluripotent stem cells. After medical training in India, Dr. Rao obtained a doctorate at The California Institute of Technology and embarked on a career in developmental biology that included faculty positions of increasing seniority at the University of Utah and the National Institutes of Health. Dr. Rao has published more than 400 papers on stem cell research and is the inventor of more than twenty patents licensed to various companies.